Corcept Therapeutics | CORT - Операционные расходы





Операционные расходы Изменить Дата
Acadia Pharmaceuticals USD 270.12M 2.55M 2026-06
Alaunos Therapeutics USD 1.01M 175K 2026-03
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Ardelyx USD 127.27M 7.15M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Eli Lilly USD 10.52B 496M 2026-06
J&J USD 18.93B 1.09B 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Merck USD 15.77B 2.4B 2026-06
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novartis USD 10.2B 912M 2026-06
Novartis USD 9.29B 507M 2026-03
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 180.54M 7.79M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06